Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws
1. Investors of PROF face a potential securities fraud investigation. 2. An error overstated PROF's revenue by $472,000 in Q1 2024. 3. Quarterly reports for 2024 are now deemed unreliable for investors. 4. PROF shares dropped by 5.9% following the revenue overstatement news.